Leptin in hepatocellular carcinoma
Authors:
- Shen-Nien WangSWShen-Nien Wang
- King Teh LeeKLKing Teh Lee
- Chen-Guo KerCKChen-Guo Ker
Open Access
- 1 January 2010
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 16 (46) , 5801-5809
Abstract
The risk factors for hepatocellular carcinoma (HCC) development have been established, and include chronic hepatitis B and C, heavy alcohol consumption, and aflatoxins. In fact, 5%-30% of patients with HCC still lack a readily identifiable risk factor. It has been reported that the majority of ‘‘cryptogenic’’ HCC may be attributed to nonalcoholic fatty liver disease, the hepatic presentation of the metabolic syndrome (MS). Obesity is associated with the development of the MS. Recently, adipose tissue has been considered as an endocrine organ because of its capacity to secrete a variety of cytokines, which are collectively known as the adipokines. Leptin, the product of the obese gene, is mainly produced by adipose tissue. Since leptin was first characterized in 1994, accumulated literature has demonstrated the involvement of this adipokine in several areas of human physiology. After binding to its receptor, leptin initiates a cascade of signaling events and subsequent cellular effects. In addition to being the regulatory mediator of energy homeostasis, several in vitro studies have demonstrated the fibrogenic role of leptin in the liver. Furthermore, the deregulated expression of leptin and its receptor have been demonstrated to be associated with a variety of metabolic disorders as well as human cancers. Most importantly, direct evidence supporting the inhibitory and/or activating role of leptin in the process of carcinogenesis and progression of human HCC has been accumulating rapidly. This review aims to provide important insights into the potential mechanisms of leptin in the development of HCC. Hopefully, further investigations will shed light on a new therapeutic target in HCC.Keywords
This publication has 92 references indexed in Scilit:
- Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosinesThe FEBS Journal, 2004
- Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver diseaseJournal of Hepatology, 2004
- SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985Journal of Biological Chemistry, 2000
- Activation of Downstream Signals by the Long Form of the Leptin ReceptorJournal of Biological Chemistry, 2000
- Obesity, insulin resistance and diabetes — a worldwide epidemicBritish Journal of Nutrition, 2000
- Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue InjuryJournal of Biological Chemistry, 2000
- The Role of SOCS-3 in Leptin Signaling and Leptin ResistanceJournal of Biological Chemistry, 1999
- Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying DiseaseHepatology, 1999
- II. Alcoholic liver injury involves activation of Kupffer cells by endotoxinAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1998
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998